Assessing the Burden of Respiratory Syncytial Virus (RSV)

Sponsor
Abu Dhabi Health Services Company
Study ID
NCT07015255
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Acute Lower Respiratory Tract Infections
  • Bronchiolitis
  • Chronic Respiratory Conditions
  • Pneumonia
  • Respiratory Syncytial Virus (RSV) Infection

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

This study examines the impact of Respiratory Syncytial Virus (RSV) on people of all ages, from infants to the elderly. It uses hospital records collected between January 2018 and December 2024 to understand: * How often does RSV occur * Who is most at risk * The long-term and financial effects of RSV

Key Dates

First listed
Jun 11, 2025
Start date
Jun 30, 2025
Status verified
Jun 2025
Primary completion
Jun 30, 2026
Completion
Jun 30, 2026

Study Design

Enrollment
1,500 participants (estimated)

Arms

  • Arm: Infants, adults, elderly, and high-risk patients with confirmed RSV infection (2018-2024).
    This retrospective study includes patients of all ages with confirmed Respiratory Syncytial Virus (RSV) infection from January 2018 to December 2024, categorized into four cohorts: (1) Infants and young children, including those with risk factors such as prematurity, low birth weight, and chronic lung or heart disease; (2) Adults aged 18-64 years with or without comorbidities; (3) Elderly adults aged 65 and older, with focus on severe outcomes and mortality; and (4) High-risk individuals across all age groups with underlying conditions such as asthma, COPD, diabetes, immunosuppression, Down syndrome, or cystic fibrosis. No interventions are administered; the study analyzes existing data to assess RSV burden, ICU admissions, long-term health impacts, and associated healthcare costs.

Primary Outcome Measure

Burden of RSV Infection Across All Age Groups [ Time Frame: January 2018 - December 2024 ]

Central Contacts

Related Studies